Tianjin Chase Sun Pharmaceutical Co Ltd
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves th… Read more
Tianjin Chase Sun Pharmaceutical Co Ltd (300026) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.017x
Based on the latest financial reports, Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a cash flow conversion efficiency ratio of 0.017x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥153.30 Million) by net assets (CN¥8.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tianjin Chase Sun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Tianjin Chase Sun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tianjin Chase Sun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianjin Chase Sun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CRISIL Limited
NSE:CRISIL
|
0.073x |
|
Shandong Laiwu Jinlei Wind Power Technology Co Ltd
SHE:300443
|
-0.010x |
|
Focus Technology Co Ltd
SHE:002315
|
0.075x |
|
Krungthai Card PCL
BK:KTC
|
0.058x |
|
Lightspeed Commerce Inc
NYSE:LSPD
|
0.044x |
|
Anhui Jinhe Industrial Co Ltd
SHE:002597
|
0.038x |
|
Tamburi Investment Partners S.p.A.
LSE:0G9J
|
0.010x |
|
Wuxi Huaguang Boiler Co Ltd
SHG:600475
|
0.066x |
Annual Cash Flow Conversion Efficiency for Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥8.80 Billion | CN¥852.24 Million | 0.097x | -43.86% |
| 2023-12-31 | CN¥8.87 Billion | CN¥1.53 Billion | 0.173x | +95.92% |
| 2022-12-31 | CN¥8.46 Billion | CN¥745.35 Million | 0.088x | +78.85% |
| 2021-12-31 | CN¥7.95 Billion | CN¥391.60 Million | 0.049x | +85.09% |
| 2020-12-31 | CN¥7.39 Billion | CN¥196.66 Million | 0.027x | -12.96% |
| 2019-12-31 | CN¥7.07 Billion | CN¥216.10 Million | 0.031x | -48.22% |
| 2018-12-31 | CN¥6.58 Billion | CN¥388.19 Million | 0.059x | -48.25% |
| 2017-12-31 | CN¥6.51 Billion | CN¥742.38 Million | 0.114x | +53.72% |
| 2016-12-31 | CN¥6.04 Billion | CN¥448.08 Million | 0.074x | +224.40% |
| 2015-12-31 | CN¥5.29 Billion | CN¥121.00 Million | 0.023x | -64.02% |
| 2014-12-31 | CN¥2.36 Billion | CN¥149.94 Million | 0.064x | -24.62% |
| 2013-12-31 | CN¥1.70 Billion | CN¥143.60 Million | 0.084x | -23.17% |
| 2012-12-31 | CN¥1.39 Billion | CN¥152.21 Million | 0.110x | +223.42% |
| 2011-12-31 | CN¥1.05 Billion | CN¥35.64 Million | 0.034x | -19.44% |
| 2010-12-31 | CN¥1.10 Billion | CN¥46.25 Million | 0.042x | -71.09% |
| 2009-12-31 | CN¥926.88 Million | CN¥135.06 Million | 0.146x | -76.47% |
| 2008-12-31 | CN¥125.51 Million | CN¥77.74 Million | 0.619x | -47.33% |
| 2007-12-31 | CN¥61.24 Million | CN¥72.01 Million | 1.176x | +1943.30% |
| 2006-12-31 | CN¥21.28 Million | CN¥1.22 Million | 0.058x | -- |